SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 70.33M
March 31, 2026 66.23M
December 31, 2025 62.68M
September 30, 2025 62.92M
June 30, 2025 62.37M
March 31, 2025 62.86M
December 31, 2024 62.21M
September 30, 2024 61.04M
June 30, 2024 61.25M
March 31, 2024 59.77M
December 31, 2023 59.02M
September 30, 2023 58.82M
June 30, 2023 57.95M
March 31, 2023 57.75M
December 31, 2022 57.25M
September 30, 2022 56.14M
June 30, 2022 55.21M
March 31, 2022 53.00M
December 31, 2021 52.03M
September 30, 2021 51.18M
June 30, 2021 49.97M
March 31, 2021 49.27M
December 31, 2020 48.17M
September 30, 2020 46.92M
June 30, 2020 45.49M
Date Value
March 31, 2020 44.82M
December 31, 2019 43.57M
September 30, 2019 42.95M
June 30, 2019 42.62M
March 31, 2019 42.70M
December 31, 2018 43.19M
September 30, 2018 42.76M
June 30, 2018 41.94M
March 31, 2018 41.45M
December 31, 2017 40.06M
September 30, 2017 39.33M
June 30, 2017 38.79M
March 31, 2017 38.25M
December 31, 2016 37.11M
September 30, 2016 35.62M
June 30, 2016 34.23M
March 31, 2016 32.84M
December 31, 2015 32.21M
September 30, 2015 32.47M
June 30, 2015 32.82M
March 31, 2015 32.15M
December 31, 2014 30.79M
September 30, 2014 29.53M
June 30, 2014 27.38M
March 31, 2014 26.28M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Cencora, Inc. 7.654B
Abbott Laboratories 13.94B
Align Technology, Inc. 1.787B
AngioDynamics, Inc. 116.41M
Accuray, Inc. 86.17M